• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗与膳食植物化学剂。

Chemotherapy and dietary phytochemical agents.

作者信息

Sak Katrin

机构信息

NGO Praeventio, Näituse 22-3, 50407 Tartu, Estonia.

出版信息

Chemother Res Pract. 2012;2012:282570. doi: 10.1155/2012/282570. Epub 2012 Dec 20.

DOI:10.1155/2012/282570
PMID:23320169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3539428/
Abstract

Chemotherapy has been used for cancer treatment already for almost 70 years by targeting the proliferation potential and metastasising ability of tumour cells. Despite the progress made in the development of potent chemotherapy drugs, their toxicity to normal tissues and adverse side effects in multiple organ systems as well as drug resistance have remained the major obstacles for the successful clinical use. Cytotoxic agents decrease considerably the quality of life of cancer patients manifesting as acute complaints and impacting the life of survivors also for years after the treatment. Toxicity often limits the usefulness of anticancer agents being also the reason why many patients discontinue the treatment. The nutritional approach may be the means of helping to raise cancer therapy to a new level of success as supplementing or supporting the body with natural phytochemicals cannot only reduce adverse side effects but improve also the effectiveness of chemotherapeutics. Various plant-derived compounds improve the efficiency of cytotoxic agents, decrease their resistance, lower and alleviate toxic side effects, reduce the risk of tumour lysis syndrome, and detoxify the body of chemotherapeutics. The personalised approach using various phytochemicals provides thus a new dimension to the standard cancer therapy for improving its outcome in a complex and complementary way.

摘要

化疗通过靶向肿瘤细胞的增殖潜能和转移能力来治疗癌症,至今已有近70年的历史。尽管在开发强效化疗药物方面取得了进展,但它们对正常组织的毒性、在多个器官系统中的不良副作用以及耐药性仍然是临床成功应用的主要障碍。细胞毒性药物会显著降低癌症患者的生活质量,表现为急性不适,并且在治疗后的数年里也会影响幸存者的生活。毒性常常限制了抗癌药物的效用,这也是许多患者中断治疗的原因。营养方法可能是帮助将癌症治疗提升到新的成功水平的手段,因为用天然植物化学物质补充或支持身体不仅可以减少不良副作用,还能提高化疗药物的有效性。各种植物衍生化合物可提高细胞毒性药物的效率,降低其耐药性,减轻毒性副作用,降低肿瘤溶解综合征的风险,并使身体对化疗药物解毒。因此,使用各种植物化学物质的个性化方法为标准癌症治疗提供了一个新的维度,以复杂且互补的方式改善其治疗效果。

相似文献

1
Chemotherapy and dietary phytochemical agents.化疗与膳食植物化学剂。
Chemother Res Pract. 2012;2012:282570. doi: 10.1155/2012/282570. Epub 2012 Dec 20.
2
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
3
Phytochemicals in Anticancer Drug Development.植物化学物质在抗癌药物开发中的应用。
Anticancer Agents Med Chem. 2019;19(2):172-183. doi: 10.2174/1871520618666181106115802.
4
Anticancer Drug Development: The Way Forward.抗癌药物研发:前进之路
Oncologist. 1996;1(3):180-181.
5
Natural compounds and combination therapy in colorectal cancer treatment.天然化合物与联合疗法在结直肠癌治疗中的应用。
Eur J Med Chem. 2018 Jan 20;144:582-594. doi: 10.1016/j.ejmech.2017.12.039. Epub 2017 Dec 16.
6
Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.多种膳食抗氧化剂可提高标准癌症疗法和实验性癌症疗法的疗效,并降低其毒性。
Integr Cancer Ther. 2004 Dec;3(4):310-22. doi: 10.1177/1534735404270936.
7
Chemoresistance in Ovarian Cancer: Prospects for New Drugs.卵巢癌的化疗耐药性:新药前景。
Anticancer Agents Med Chem. 2021;21(6):668-678. doi: 10.2174/1871520620666200908104835.
8
Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.AferBio® 对晚期肺癌患者生活质量和化疗毒性的影响(AFERBIO 研究):一项 II 期随机对照试验的方案研究。
BMC Cancer. 2019 Apr 25;19(1):382. doi: 10.1186/s12885-019-5599-z.
9
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
10
Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects.癌症化疗期间的膳食抗氧化剂:对化疗效果和副作用发生的影响
Nutr Cancer. 2000;37(1):1-18. doi: 10.1207/S15327914NC3701_1.

引用本文的文献

1
Exploring Phytochemical Adjuvant Therapy in Melanoma Treatment: The Effects of MAZ-51 and Zingerone on Melanoma Cell Proliferation.探索植物化学辅助疗法在黑色素瘤治疗中的应用:MAZ-51和姜辣素对黑色素瘤细胞增殖的影响。
Clin Exp Pharmacol Physiol. 2025 Sep;52(9):e70059. doi: 10.1111/1440-1681.70059.
2
New quinazoline-[1,2,4]triazolo[3,4-][1,3,4]thiadiazines as inhibitors of EGFR: synthesis, anti-breast cancer evaluation and studies.新型喹唑啉-[1,2,4]三唑并[3,4-][1,3,4]噻二嗪类化合物作为表皮生长因子受体(EGFR)抑制剂:合成、抗乳腺癌活性评价及相关研究
RSC Med Chem. 2025 Jul 18. doi: 10.1039/d5md00103j.
3
Enhancing the therapeutic potential of FDA-approved ifosfamide and 5-fluorouracil through rational chemical modifications for endometrial cancer treatment.通过合理的化学修饰提高美国食品药品监督管理局批准的异环磷酰胺和5-氟尿嘧啶治疗子宫内膜癌的潜力。
Med Oncol. 2025 Jun 25;42(8):281. doi: 10.1007/s12032-025-02821-2.
4
A Narrative Review of Quercetin's Role as a Bioactive Compound in Female Reproductive Disorders.槲皮素作为生物活性化合物在女性生殖系统疾病中作用的叙述性综述
Nutrients. 2025 Mar 24;17(7):1118. doi: 10.3390/nu17071118.
5
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer.肺癌中基因、表观遗传和代谢改变的分子机制。
Med Oncol. 2025 Feb 2;42(3):61. doi: 10.1007/s12032-025-02608-5.
6
Exploring the Relationship Between Dietary Phytochemical Index and Chemotherapy-Related Symptoms: Insights From a Cross-Sectional Study.探索饮食植物化学物指数与化疗相关症状之间的关系:一项横断面研究的见解
Food Sci Nutr. 2024 Nov 7;12(12):10306-10314. doi: 10.1002/fsn3.4568. eCollection 2024 Dec.
7
Utilizing Indigenous Flora in East Africa for Breast Cancer Treatment: An Overview.利用东非本土植物治疗乳腺癌:概述
Anticancer Agents Med Chem. 2025;25(2):99-113. doi: 10.2174/0118715206338557240909081833.
8
Modifications of Nanobubble Therapy for Cancer Treatment.纳米气泡治疗癌症的改进。
Int J Mol Sci. 2024 Jul 2;25(13):7292. doi: 10.3390/ijms25137292.
9
Biomaterials in Cancer Therapy: Investigating the Interaction between Kaempferol and Zinc Ions through Computational, Spectroscopic and Biological Analyses.癌症治疗中的生物材料:通过计算、光谱和生物学分析研究山奈酚与锌离子之间的相互作用
Materials (Basel). 2024 May 24;17(11):2526. doi: 10.3390/ma17112526.
10
Silibinin, Synergistically Enhances Vinblastine-Mediated Apoptosis in Triple Negative Breast Cancer Cell Line: Involvement of Bcl2/Bax and Caspase-3 Pathway.水飞蓟宾协同增强长春碱介导的三阴性乳腺癌细胞系凋亡:Bcl2/Bax和Caspase-3信号通路的作用
Int J Hematol Oncol Stem Cell Res. 2024 Apr 1;18(2):174-182. doi: 10.18502/ijhoscr.v18i2.15375.

本文引用的文献

1
P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.P-糖蛋白及其在肿瘤中的抑制作用——来自中草药的植物化学物质。
J Ethnopharmacol. 2012 Jun 1;141(2):557-70. doi: 10.1016/j.jep.2011.08.053. Epub 2011 Sep 21.
2
The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy.药物转运体介导的多药耐药性对癌症化疗的出现。
Mol Pharm. 2011 Dec 5;8(6):1996-2011. doi: 10.1021/mp200261n. Epub 2011 Jul 26.
3
Aging and inflammation: etiological culprits of cancer.衰老与炎症:癌症的病因罪魁祸首。
Curr Aging Sci. 2009 Dec;2(3):174-86. doi: 10.2174/1874609810902030174.
4
Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia.维生素E和N-乙酰半胱氨酸作为急性淋巴细胞白血病患儿的抗氧化辅助治疗
Adv Hematol. 2009;2009:689639. doi: 10.1155/2009/689639. Epub 2009 Oct 20.
5
Cancer research: from folate antagonism to molecular targets.癌症研究:从叶酸拮抗作用到分子靶点。
Best Pract Res Clin Haematol. 2009 Dec;22(4):577-82. doi: 10.1016/j.beha.2009.09.004.
6
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.定义缺氧诱导因子 1 在癌症生物学和治疗学中的作用。
Oncogene. 2010 Feb 4;29(5):625-34. doi: 10.1038/onc.2009.441. Epub 2009 Nov 30.
7
Metabolism and cancer: the circadian clock connection.代谢与癌症:生物钟的联系。
Nat Rev Cancer. 2009 Dec;9(12):886-96. doi: 10.1038/nrc2747.
8
Ginseng leaf-stem: bioactive constituents and pharmacological functions.人参茎叶:生物活性成分及药理作用。
Chin Med. 2009 Oct 22;4:20. doi: 10.1186/1749-8546-4-20.
9
Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.癌症治疗中化疗耐药的机制——简要综述
Taiwan J Obstet Gynecol. 2009 Sep;48(3):239-44. doi: 10.1016/S1028-4559(09)60296-5.
10
Adenosine receptors and cancer.腺苷受体与癌症。
Handb Exp Pharmacol. 2009(193):399-441. doi: 10.1007/978-3-540-89615-9_14.